Shorla Oncology | ApexOnco - Clinical Trials news and analysis

“Top quality, fast and so easy to use”

Director New Product Planning

Morphosys

Click here for more information

Data insights Regulatory

3 December 2024

Autolous, Syndax, Jazz and Shorla get US approvals in a quiet month.

Data insights

31 October 2024

Conferences ramp up, and ASH abstracts near.

Recent Quick take